Kernal Biologics' vision is to develop curative immunotherapies for cancers with high unmet medical need by using deep learning and synthetic biology.Thanks to Kernal's unique methods of codon-engineering and smart design, their proprietary platform decreases immunogenicity upon existing mRNA technologies and enables cell-specific therapeutic protein expression. Allowing Kernal to design and develop more efficacious, tolerable, and affordable medicine for the global market.
Category Digital Health Company
Buyer Pharma
Setting Other
User Pharma
Purpose Clinical Research